Crossmark

Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA

Crossref DOI link: https://doi.org/10.1186/s12859-019-2628-5

Published Online: 2019-03-14

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wu, Leihong

Ingle, Taylor

Liu, Zhichao

Zhao-Wong, Anna

Harris, Stephen

Thakkar, Shraddha

Zhou, Guangxu

Yang, Junshuang

Xu, Joshua

Mehta, Darshan

Ge, Weigong

Tong, Weida

Fang, Hong
License Information

Text and Data Mining valid from 2019-03-01
More Information

Article History

First Online: 14 March 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.